Västra Hamnen Corporate Finance initiates Research Coverage on Scandinavian ChemoTech
Scandinavian ChemoTech AB (publ) and Västra Hamnen Corporate Finance AB (VH) have signed a contract to perform commissioned equity research.In its initial research report, VH writes the following: ”ChemoTech is a young medical technology company in the first stage of commercialising its innovative equipment for cancer treatment. The company has redeveloped electrochemotherapy, a proven method for tumour treatment, and created a solution which is both effective and much cheaper than competing methods. ChemoTech may thereby bring much needed treatment to cancer patients in the developing